已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

COVID-19 Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season

医学 接种疫苗 观察研究 流行病学 儿科 急诊科 随机对照试验 疾病 梅德林 急诊医学 系统回顾 相对风险 医疗保健 临床试验 入射(几何) 重症监护医学 荟萃分析 疫苗安全性 风险因素 不利影响
作者
Rachel A. Lipson,Emily Senerth,Michelle A. Watson,Harseerat Saini,Jordan Falk,Neha Tangri,Seyyedeh Mahsa Sheikholeslamian,Kapeena Sivakumaran,Ifeoluwa Babatunde,Melinda E. Wharton,Angela K. Ulrich,Leah E. Moat,Clare J. Stoddart,Elise J. Holmes,Rochelle P. Walensky,Nicole E. Basta,Rebecca L. Morgan
出处
期刊:JAMA [American Medical Association]
被引量:4
标识
DOI:10.1001/jama.2026.18191
摘要

Importance: SARS-CoV-2 remains a substantial cause of respiratory illness, morbidity, and mortality. Evidence to date has demonstrated that COVID-19 vaccines reduce the risk of severe disease, including hospitalization and death. Objective: This systematic review identifies and summarizes newly published studies reporting on the effectiveness and safety of COVID-19 vaccines and COVID-19 epidemiology in the US. Evidence Review: Cochrane Central Register of Controlled Trials, PubMed/MEDLINE, Embase, and Scopus were searched from August 1, 2025, through June 29, 2026. Studies were eligible if they reported on the effectiveness, efficacy, or safety of a US-licensed COVID-19 vaccine or SARS-CoV-2 epidemiology in the US. Findings: From 11 829 identified references, 155 publications were eligible (15 randomized clinical trials, 84 observational studies with a comparator group, 38 product safety studies without a comparator group [single group], and 18 descriptive studies of disease burden). Consistent with prior evidence, studies reported that updated COVID-19 vaccines were associated with a reduction in the risk of hospitalization among both older adults (≥65 years; vaccine effectiveness [VE], 53.0%; 95% CI, 37.0%-65.0%; 2025-2026 season) and adults (18-64 years; VE, 54.0%; 95% CI, 1.0%-78.0%; 2024-2025 season). Maternal vaccination was associated with reduced risk of COVID-19-associated emergency department/urgent care encounters among individuals vaccinated (VE, 58.0%; 95% CI, 24.0%-77.0%) and with fewer COVID-19-related hospital contacts in the first 2 months of life among infants born subsequently (VE range, 50.0%-54.0%), regardless of trimester of vaccination. Vaccination was also associated with a significant reduction in COVID-19-related pediatric emergency department visits (9 months to 4 years; VE, 76.0%; 95% CI, 58.0%-87.0%). Vaccination was associated with a reduced risk of critical COVID-19 illness (intensive care unit admission or death) in immunocompromised adults (VE range, 32.0%-53.0%, depending on condition and other factors). Health care personnel who received 3 to 5 vaccine doses were less likely to develop laboratory-confirmed COVID-19 illness (VE, 41.0%; 95% CI, 34.0%-47.0%) and postacute COVID-19 symptoms (VE, 57.0%; 95% CI, 46.0%-66.0%) compared with those who received only 2 doses. Across adverse events of special interest (eg, stroke, thrombosis, myocarditis), safety profiles were consistent with those of previous reviews. No identified studies conducted under the updated guidance on extended dosing intervals for the primary series reported an increased risk of myocarditis or pericarditis. No new safety signals were reported in the recently published studies eligible for this updated review of US-licensed COVID-19 vaccines. Conclusions and Relevance: COVID-19 vaccines were consistently associated with a reduction in the risk of hospitalization and other outcomes, including among individuals at high risk of severe COVID-19, such as infants, and those who were pregnant. No new safety concerns were identified.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
爱学习小羊完成签到 ,获得积分10
1秒前
3秒前
逍遥游发布了新的文献求助10
8秒前
槐桉完成签到 ,获得积分0
11秒前
阿垚完成签到,获得积分10
12秒前
13秒前
OMIT发布了新的文献求助10
14秒前
15秒前
15秒前
qingsi完成签到 ,获得积分10
16秒前
18秒前
逍遥游完成签到,获得积分10
18秒前
科研通AI6.3的应助被爱you采纳,获得10
19秒前
Lisa发布了新的文献求助10
21秒前
21秒前
肖宇完成签到,获得积分10
21秒前
激动的严青完成签到,获得积分10
22秒前
Akim的应助被普鲁卡因采纳,获得10
23秒前
24秒前
关我屁事完成签到 ,获得积分10
25秒前
凶狠的姚完成签到 ,获得积分10
25秒前
豆豆完成签到 ,获得积分10
28秒前
直率的晓亦完成签到,获得积分10
28秒前
111发布了新的文献求助10
28秒前
羡慕尽天的一天完成签到 ,获得积分10
29秒前
29秒前
冷静新烟完成签到,获得积分10
30秒前
天天快乐的应助被诸葛明明采纳,获得10
30秒前
阿阿撒完成签到 ,获得积分10
32秒前
清新的夜蕾完成签到 ,获得积分10
32秒前
在水一方的应助被枫叶-ZqqC采纳,获得10
33秒前
40秒前
枫叶-ZqqC完成签到,获得积分10
43秒前
45秒前
46秒前
CipherSage的应助被开心的中心采纳,获得10
47秒前
枫叶-ZqqC发布了新的文献求助10
47秒前
wanci的应助被win采纳,获得10
48秒前
李健的应助被gege_432采纳,获得10
53秒前
Lazy完成签到,获得积分10
57秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179592
求助须知:如何正确求助?哪些是违规求助? 9569910
关于积分的说明 21807526
捐赠科研通 7775056
什么是DOI,文献DOI怎么找? 3433072
关于科研通互助平台的介绍 2557032
邀请新用户注册赠送积分活动 2478760